Brief: Yichang HEC ChangJiang Pharmaceutical Posts FY Revenue RMB2,348.11 Mln
March 19 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd 1558.HK :
* FY REVENUE WAS RMB2,348.11 MILLION, DOWN 62.27%
* FY PROFIT AND TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE
RMB590.21
MILLION, DECREASE OF 71.83%
Source text for Eikon: urn:newsml:reuters.com:*:nHKS675PdX
Further company coverage: 1558.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million